DP068 | ANTI-CD19 CAR-T IS EFFECTIVE IN SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA REFRACTORY TO HIGH-DOSE METHOTREXATE-BASED CHEMOTHERAPY
Introduction: Secondary involvement of the CNS is a complication of large B cell lymphomas (LBCL). Treatment of SCNSL differs from systemic lymphomas and is based on high dose chemotherapy (CHT) with drugs that penetrate the blood-brain barrier, HDMTX in particular, followed by autologous stem cell...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Ferrata Storti Foundation
2025-09-01
|
| Schriftenreihe: | Haematologica |
| Online-Zugang: | https://haematologica.org/article/view/12722 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
